Topic: atypical antipsychotics
Fanapt maker Vanda has launched a national TV awareness campaign about akathisia, a little-known side effect of some schizophrenia drugs.
Another jury smacked J&J with damages in a Risperdal breast-development case. But this time, that verdict came to $70M--far more than previous verdicts in similar cases.
Back in September, Otsuka and partner Proteus Digital Health submitted an application to the FDA for their new drug adherence device. The agency reviewed the submission and, underwhelmed by what it found, said that it needs more information before it gives its final stamp of approval.